Lisa Wilmes • UCSF Profiles

Lisa Wilmes, PhD

Title(s)	Specialist, Radiology
School	School of Medicine
Address	550 16th Street, #7371 San Francisco CA 94158
Phone	415-885-7297
vCard	Download vCard

Bibliographic

Publications

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.

Altmetrics Details

PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.

Abstract P6-01-33: Diffusion-weighted magnetic resonance imaging for subtype-specific prediction of pathologic complete response in neoadjuvant chemotherapy. Cancer Research. 2023 Mar 1; 83(5_Supplement):p6-01-33-p6-01-33. Zimmermann ZJ, Carmona-Bozo CJ, Le LN, Onishi ON, Wilmes WL, Gibbs GJ, Liang LJ, Newitt ND, Partridge PS, Bolan BP, Joe JB, Price PE, LeStage LB, Hylton HN, Li LW. .

View in: Publisher Site Mentions:
Abstract PD16-07: Association of MRI morphologic phenotype from unsupervised learning with breast cancer subtypes and treatment response. Cancer Research. 2023 Mar 1; 83(5_Supplement):pd16-07-pd16-07. Le LN, Onishi ON, Newitt ND, Gibbs GJ, Wilmes WL, Gennatas GE, LeStage LB, Esserman EL, Hylton HN, Li LW. .

View in: Publisher Site Mentions:
Chapter 14 Multiplatform Standardization of Breast DWI Protocols: Quality Control and Test Objects. . 2023 Jan 1; 220-243. Malyarenko MD, Wilmes WL, Chenevert CT. .

View in: Publisher Site Mentions:
Diffusion-Weighted MRI for Predicting Pathologic Complete Response in Neoadjuvant Immunotherapy. Cancers (Basel). 2022 Sep 13; 14(18). Li W, Le NN, Onishi N, Newitt DC, Wilmes LJ, Gibbs JE, Carmona-Bozo J, Liang J, Partridge SC, Price ER, Joe BN, Kornak J, Magbanua MJM, Nanda R, LeStage B, Esserman LJ, Van't Veer LJ, Hylton NM. PMID: 36139594; PMCID: PMC9497087.

View in: PubMed Mentions: 2
Effect of Inter-Reader Variability on Diffusion-Weighted MRI Apparent Diffusion Coefficient Measurements and Prediction of Pathologic Complete Response for Breast Cancer. Tomography. 2022 04 22; 8(3):1208-1220. Le NN, Li W, Onishi N, Newitt DC, Gibbs JE, Wilmes LJ, Kornak J, Partridge SC, LeStage B, Price ER, Joe BN, Esserman LJ, Hylton NM. PMID: 35645385; PMCID: PMC9149942.

View in: PubMed Mentions: 1 Fields:
Dia Diagnostic Imaging
Translation:Humans
Abstract P3-03-02: Diffusion-weighted MRI for prediction of pathologic complete response in HER2- breast cancer treated with pembrolizumab plus neoadjuvant chemotherapy. Cancer Research. 2022 Feb 15; 82(4_Supplement):p3-03-02-p3-03-02. Li LW, Le LN, Onishi ON, Newitt ND, Gibbs GJ, Wilmes WL, Kornak KJ, Partridge PS, LeStage LB, Price PE, Joe JB, Esserman EL, Hylton HN. .

View in: Publisher Site Mentions:
Long-Term Stability of Gradient Characteristics Warrants Model-Based Correction of Diffusion Weighting Bias. Tomography. 2022 02 04; 8(1):364-375. Pang Y, Malyarenko DI, Wilmes LJ, Devaraj A, Tan ET, Marinelli L, Endt AV, Peeters J, Jacobs MA, Newitt DC, Chenevert TL. PMID: 35202195; PMCID: PMC8875771.

View in: PubMed Mentions: 1 Fields:
Dia Diagnostic Imaging
Breast MRI during Neoadjuvant Chemotherapy: Lack of Background Parenchymal Enhancement Suppression and Inferior Treatment Response. Radiology. 2021 11; 301(2):295-308. Onishi N, Li W, Newitt DC, Harnish RJ, Strand F, Nguyen AA, Arasu VA, Gibbs J, Jones EF, Wilmes LJ, Kornak J, Joe BN, Price ER, Ojeda-Fournier H, Eghtedari M, Zamora KW, Woodard S, Umphrey HR, Nelson MT, Church AL, Bolan PJ, Kuritza T, Ward K, Morley K, Wolverton D, Fountain K, Lopez Paniagua D, Hardesty L, Brandt KR, McDonald ES, Rosen M, Kontos D, Abe H, Sheth D, Crane E, Dillis C, Sheth P, Hovanessian-Larsen L, Bang DH, Porter B, Oh KY, Jafarian N, Tudorica LA, Niell B, Drukteinis J, Newell MS, Giurescu ME, Berman E, Lehman CD, Partridge SC, Fitzpatrick KA, Borders MH, Yang WT, Dogan B, Goudreau SH, Chenevert T, Yau C, DeMichele A, Berry DA, Esserman LJ, Hylton NM. PMID: 34427465; PMCID: PMC8574064.

View in: PubMed Mentions: 8 Fields:
Rad Radiology
Translation:Humans
Abstract PS11-08: Operational standardization and quality assurance yield high acceptance rate for breast MRI in the I-SPY 2 TRIAL. Cancer Research. 2021 Feb 15; 81(4_Supplement):ps11-08-ps11-08. Gibbs GJ, Newitt ND, Watkins WM, Li LW, Cimino CL, Li LC, Onishi ON, Wilmes WL, Bareng BT, Proctor PE, LeStage LB, Parker PB, Hylton HN. .

View in: Publisher Site Mentions:
Abstract PD6-05: Subtype-specific MRI models to guide selection of candidates for de-escalation of neoadjuvant therapy. Cancer Research. 2021 Feb 15; 81(4_Supplement):pd6-05-pd6-05. Li LW, Newitt ND, Gibbs GJ, Wilmes WL, Jones JE, Onishi ON, Joe JB, Price PE, Kornak KJ, Yau YC, Wolf WD, LeStage LB, Samson SS, Esserman EL, Hylton HN. .

View in: Publisher Site Mentions:
Factors Affecting Image Quality and Lesion Evaluability in Breast Diffusion-weighted MRI: Observations from the ECOG-ACRIN Cancer Research Group Multisite Trial (A6702). J Breast Imaging. 2021 Jan-Feb; 3(1):44-56. Whisenant JG, Romanoff J, Rahbar H, Kitsch AE, Harvey SM, Moy L, DeMartini WB, Dogan BE, Yang WT, Wang LC, Joe BN, Wilmes LJ, Hylton NM, Oh KY, Tudorica LA, Neal CH, Malyarenko DI, McDonald ES, Comstock CE, Yankeelov TE, Chenevert TL, Partridge SC. PMID: 33543122; PMCID: PMC7835633.

View in: PubMed Mentions: 3
Denoising and Multiple Tissue Compartment Visualization of Multi-b-Valued Breast Diffusion MRI. Journal of Magnetic Resonance Imaging. 2020 Dec 12; 53(1):spcone-spcone. Tan TE, Wilmes WL, Joe JB, Onishi ON, Arasu AV, Hylton HN, Marinelli ML, Newitt ND. .

View in: Publisher Site Mentions:
Predicting breast cancer response to neoadjuvant treatment using multi-feature MRI: results from the I-SPY 2 TRIAL. NPJ Breast Cancer. 2020 Nov 27; 6(1):63. Li W, Newitt DC, Gibbs J, Wilmes LJ, Jones EF, Arasu VA, Strand F, Onishi N, Nguyen AA, Kornak J, Joe BN, Price ER, Ojeda-Fournier H, Eghtedari M, Zamora KW, Woodard SA, Umphrey H, Bernreuter W, Nelson M, Church AL, Bolan P, Kuritza T, Ward K, Morley K, Wolverton D, Fountain K, Lopez-Paniagua D, Hardesty L, Brandt K, McDonald ES, Rosen M, Kontos D, Abe H, Sheth D, Crane EP, Dillis C, Sheth P, Hovanessian-Larsen L, Bang DH, Porter B, Oh KY, Jafarian N, Tudorica A, Niell BL, Drukteinis J, Newell MS, Cohen MA, Giurescu M, Berman E, Lehman C, Partridge SC, Fitzpatrick KA, Borders MH, Yang WT, Dogan B, Goudreau S, Chenevert T, Yau C, DeMichele A, Berry D, Esserman LJ, Hylton NM. PMID: 33298938; PMCID: PMC7695723.

View in: PubMed Mentions: 16
Mean Apparent Diffusion Coefficient Is a Sufficient Conventional Diffusion-weighted MRI Metric to Improve Breast MRI Diagnostic Performance: Results from the ECOG-ACRIN Cancer Research Group A6702 Diffusion Imaging Trial. Radiology. 2021 01; 298(1):60-70. McDonald ES, Romanoff J, Rahbar H, Kitsch AE, Harvey SM, Whisenant JG, Yankeelov TE, Moy L, DeMartini WB, Dogan BE, Yang WT, Wang LC, Joe BN, Wilmes LJ, Hylton NM, Oh KY, Tudorica LA, Neal CH, Malyarenko DI, Comstock CE, Schnall MD, Chenevert TL, Partridge SC. PMID: 33201788; PMCID: PMC7771995.

View in: PubMed Mentions: 14 Fields:
Rad Radiology
Translation:Humans
Denoising and Multiple Tissue Compartment Visualization of Multi-b-Valued Breast Diffusion MRI. J Magn Reson Imaging. 2021 01; 53(1):271-282. Tan ET, Wilmes LJ, Joe BN, Onishi N, Arasu VA, Hylton NM, Marinelli L, Newitt DC. PMID: 32614125; PMCID: PMC8406040.

View in: PubMed Mentions: 2 Fields:
Dia Diagnostic Imaging
Translation:Humans
Impact of MRI Protocol Adherence on Prediction of Pathological Complete Response in the I-SPY 2 Neoadjuvant Breast Cancer Trial. Tomography. 2020 06; 6(2):77-85. Onishi N, Li W, Gibbs J, Wilmes LJ, Nguyen A, Jones EF, Arasu V, Kornak J, Joe BN, Esserman LJ, Newitt DC, Hylton NM. PMID: 32548283; PMCID: PMC7289255.

View in: PubMed Mentions: 4 Fields:
Dia Diagnostic Imaging
Translation:Humans
Tumor Sphericity Predicts Response in Neoadjuvant Chemotherapy for Invasive Breast Cancer. Tomography. 2020 06; 6(2):216-222. Li W, Newitt DC, Yun B, Jones EF, Arasu V, Wilmes LJ, Gibbs J, Nguyen AA, Onishi N, Kornak J, Joe BN, Esserman LJ, Hylton NM. PMID: 32548299; PMCID: PMC7289243.

View in: PubMed Mentions: 5 Fields:
Dia Diagnostic Imaging
Translation:Humans
Retrospective Correction of ADC for Gradient Nonlinearity Errors in Multicenter Breast DWI Trials: ACRIN6698 Multiplatform Feasibility Study. Tomography. 2020 06; 6(2):86-92. Malyarenko DI, Newitt DC, Amouzandeh G, Wilmes LJ, Tan ET, Marinelli L, Devaraj A, Peeters JM, Giri S, Vom Endt A, Hylton NM, Partridge SC, Chenevert TL. PMID: 32548284; PMCID: PMC7289257.

View in: PubMed Mentions: 3 Fields:
Dia Diagnostic Imaging
Translation:Humans
Role of Breast MRI in the Evaluation and Detection of DCIS: Opportunities and Challenges. J Magn Reson Imaging. 2020 09; 52(3):697-709. Greenwood HI, Wilmes LJ, Kelil T, Joe BN. PMID: 31746088.

View in: PubMed Mentions: 12 Fields:
Dia Diagnostic Imaging
Translation:Humans
Additive value of diffusion-weighted MRI in the I-SPY 2 TRIAL. J Magn Reson Imaging. 2019 12; 50(6):1742-1753. Li W, Newitt DC, Wilmes LJ, Jones EF, Arasu V, Gibbs J, La Yun B, Li E, Partridge SC, Kornak J, I-SPY 2 Consortium, Esserman LJ, Hylton NM. PMID: 31026118; PMCID: PMC6815231.

View in: PubMed Mentions: 18 Fields:
Dia Diagnostic Imaging
Translation:Humans
Recommendations towards standards for quantitative MRI (qMRI) and outstanding needs. J Magn Reson Imaging. 2019 Jun; 49(7):e26-e39. Keenan KE, Biller JR, Delfino JG, Boss MA, Does MD, Evelhoch JL, Griswold MA, Gunter JL, Hinks RS, Hoffman SW, Kim G, Lattanzi R, Li X, Marinelli L, Metzger GJ, Mukherjee P, Nordstrom RJ, Peskin AP, Perez E, Russek SE, Sahiner B, Serkova N, Shukla-Dave A, Steckner M, Stupic KF, Wilmes LJ, Wu HH, Zhang H, Jackson EF, Sullivan DC. PMID: 30680836; PMCID: PMC6663309.

View in: PubMed Mentions: 36 Fields:
Dia Diagnostic Imaging
Translation:Humans
Abstract P2-09-23: Diffusion-weighted MRI improves imaging prediction of response in the I-SPY 2 trial. Poster Session Abstracts. 2018 Feb 15; p2-09-23-p2-09-23. Li LW, Wilmes WL, Newitt ND, Jones JE, Gibbs GJ, Poon PM, Li LE, Partridge PS, Kornak KJ, Esserman EL, Hylton HN. .

View in: Publisher Site Mentions:
Accuracy, repeatability, and interplatform reproducibility of T1 quantification methods used for DCE-MRI: Results from a multicenter phantom study. Magn Reson Med. 2018 05; 79(5):2564-2575. Bane O, Hectors SJ, Wagner M, Arlinghaus LL, Aryal MP, Cao Y, Chenevert TL, Fennessy F, Huang W, Hylton NM, Kalpathy-Cramer J, Keenan KE, Malyarenko DI, Mulkern RV, Newitt DC, Russek SE, Stupic KF, Tudorica A, Wilmes LJ, Yankeelov TE, Yen YF, Boss MA, Taouli B. PMID: 28913930; PMCID: PMC5821553.

View in: PubMed Mentions: 41 Fields:
Dia Diagnostic Imaging
Translation:Humans
Heterogeneous drug penetrance of veliparib and carboplatin measured in triple negative breast tumors. Breast Cancer Res. 2017 Sep 11; 19(1):107. Bartelink IH, Prideaux B, Krings G, Wilmes L, Lee PRE, Bo P, Hann B, Coppé JP, Heditsian D, Swigart-Brown L, Jones EF, Magnitsky S, Keizer RJ, de Vries N, Rosing H, Pawlowska N, Thomas S, Dhawan M, Aggarwal R, Munster PN, Esserman LJ, Ruan W, Wu AHB, Yee D, Dartois V, Savic RM, Wolf DM, van 't Veer L. PMID: 28893315; PMCID: PMC5594551.

View in: PubMed Mentions: 6 Fields:
Neo Neoplasms
Translation:Humans Animals Cells
Abstract PD3-05: Effect of MR imaging contrast kinetic thresholds for prediction of neoadjuvant chemotherapy response in breast cancer subtypes – Results from ACRIN 6657 / I-SPY 1 trial. Poster Discussion Abstracts. 2017 Feb 15; pd3-05-pd3-05. Li LW, Arasu AV, Jones JE, Newitt ND, Wilmes WL, Kornak KJ, Esserman EL, Hylton HN. .

View in: Publisher Site Mentions:
Diffusion Tensor Imaging for Assessment of Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer. Tomography. 2016 Dec; 2(4):438-447. Wilmes LJ, Li W, Shin HJ, Newitt DC, Proctor E, Harnish R, Hylton NM. PMID: 29527574; PMCID: PMC5844277.

View in: PubMed Mentions: 4 Fields:
Dia Diagnostic Imaging
QIN DAWG Validation of Gradient Nonlinearity Bias Correction Workflow for Quantitative Diffusion-Weighted Imaging in Multicenter Trials. Tomography. 2016 Dec; 2(4):396-405. Malyarenko DI, Wilmes LJ, Arlinghaus LR, Jacobs MA, Huang W, Helmer KG, Taouli B, Yankeelov TE, Newitt D, Chenevert TL. PMID: 28105469; PMCID: PMC5241082.

View in: PubMed Mentions: 9 Fields:
Dia Diagnostic Imaging
Effect of MR Imaging Contrast Thresholds on Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer Subtypes: A Subgroup Analysis of the ACRIN 6657/I-SPY 1 TRIAL. Tomography. 2016 Dec; 2(4):378-387. Li W, Arasu V, Newitt DC, Jones EF, Wilmes L, Gibbs J, Kornak J, Joe BN, Esserman LJ, Hylton NM, ACRIN 6657 Trial Team and I-SPY Investigators Network. PMID: 28066808; PMCID: PMC5214452.

View in: PubMed Mentions: 13 Fields:
Dia Diagnostic Imaging
Variability and bias assessment in breast ADC measurement across multiple systems. J Magn Reson Imaging. 2016 10; 44(4):846-55. Keenan KE, Peskin AP, Wilmes LJ, Aliu SO, Jones EF, Li W, Kornak J, Newitt DC, Hylton NM. PMID: 27008431; PMCID: PMC5098898.

View in: PubMed Mentions: 12 Fields:
Dia Diagnostic Imaging
Translation:Humans
Design of a breast phantom for quantitative MRI. J Magn Reson Imaging. 2016 09; 44(3):610-9. Keenan KE, Wilmes LJ, Aliu SO, Newitt DC, Jones EF, Boss MA, Stupic KF, Russek SE, Hylton NM. PMID: 26949897; PMCID: PMC4983524.

View in: PubMed Mentions: 24 Fields:
Dia Diagnostic Imaging
Translation:Humans
Effect of Imaging Parameter Thresholds on MRI Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer Subtypes. PLoS One. 2016; 11(2):e0142047. Lo WC, Li W, Jones EF, Newitt DC, Kornak J, Wilmes LJ, Esserman LJ, Hylton NM. PMID: 26886725; PMCID: PMC4757528.

View in: PubMed Mentions: 8 Fields:
Med Medicine (General)Sci Science
Translation:Humans
Abstract C61: Non-homogeneous drug penetrance of veliparib measured in triple negative breast tumors. Drug Metabolism, Transport, and Biodistribution. 2015 Dec 1; c61-c61. Bartelink BI, Prideaux PB, Krings KG, Wilmes WL, Lee LP, Hann HB, Coppé CJ, Heditsian HD, Swigart-Brown SL, Jones JE, Magnitsky MS, Keizer KR, Esserman EL, Ruan RW, Wu WA, Yee YD, Dartois DV, Wolf WD, Savic SR, vantVeer vL. .

View in: Publisher Site Mentions:
Gradient nonlinearity correction to improve apparent diffusion coefficient accuracy and standardization in the american college of radiology imaging network 6698 breast cancer trial. J Magn Reson Imaging. 2015 Oct; 42(4):908-19. Newitt DC, Tan ET, Wilmes LJ, Chenevert TL, Kornak J, Marinelli L, Hylton N. PMID: 25758543; PMCID: PMC4629811.

View in: PubMed Mentions: 29 Fields:
Dia Diagnostic Imaging
Translation:Humans CTClinical Trials
Repeatability of quantitative MRI measurements in normal breast tissue. Transl Oncol. 2014 Feb; 7(1):130-7. Aliu SO, Jones EF, Azziz A, Kornak J, Wilmes LJ, Newitt DC, Suzuki SA, Klifa C, Gibbs J, Proctor EC, Joe BN, Hylton NM. PMID: 24772216; PMCID: PMC3998684.

View in: PubMed Mentions: 9
High resolution in vivo characterization of apparent diffusion coefficient at the tumor-stromal boundary of breast carcinomas: a pilot study to assess treatment response using proximity-dependent diffusion-weighted imaging. J Magn Reson Imaging. 2014 May; 39(5):1308-13. McLaughlin RL, Newitt DC, Wilmes LJ, Jones EF, Wisner DJ, Kornak J, Proctor E, Joe BN, Hylton NM. PMID: 24719242; PMCID: PMC3983569.

View in: PubMed Mentions: 12 Fields:
Dia Diagnostic Imaging
Translation:Humans CTClinical Trials
High-resolution diffusion-weighted imaging for monitoring breast cancer treatment response. Acad Radiol. 2013 May; 20(5):581-9. Wilmes LJ, McLaughlin RL, Newitt DC, Singer L, Sinha SP, Proctor E, Wisner DJ, Saritas EU, Kornak J, Shankaranarayanan A, Banerjee S, Jones EF, Joe BN, Hylton NM. PMID: 23570936; PMCID: PMC4507576.

View in: PubMed Mentions: 17 Fields:
Rad Radiology
Translation:Humans
High-resolution diffusion-weighted magnetic resonance imaging in patients with locally advanced breast cancer. Acad Radiol. 2012 May; 19(5):526-34. Singer L, Wilmes LJ, Saritas EU, Shankaranarayanan A, Proctor E, Wisner DJ, Chang B, Joe BN, Nishimura DG, Hylton NM. PMID: 22197382; PMCID: PMC3319166.

View in: PubMed Mentions: 33 Fields:
Rad Radiology
Translation:Humans
P2-09-12: High Resolution Diffusion MRI Characterizes Tumor Stromal Boundaries. Poster Session Abstracts. 2011 Dec 15; p2-09-12-p2-09-12. McLaughlin MR, Newitt ND, Wilmes WL, Sinha SS, Wisner WD, Hylton HN. .

View in: Publisher Site Mentions:
P2-08-06: Improved Spatial Resolution Diffusion-Weighted Imaging for Characterizing Tumors and Treatment Response in Patients with Invasive Breast Cancer. Poster Session Abstracts. 2011 Dec 15; p2-08-06-p2-08-06. Wilmes WL, McLaughlin MR, Sinha SS, Singer SL, Proctor PE, Wisner WD, Newitt ND, Shankaranarayanan SA, Joe JB, Hylton HN. .

View in: Publisher Site Mentions:
Diffusion-weighted MRI: influence of intravoxel fat signal and breast density on breast tumor conspicuity and apparent diffusion coefficient measurements. Magn Reson Imaging. 2011 Nov; 29(9):1215-21. Partridge SC, Singer L, Sun R, Wilmes LJ, Klifa CS, Lehman CD, Hylton NM. PMID: 21920686; PMCID: PMC3199288.

View in: PubMed Mentions: 32 Fields:
Dia Diagnostic Imaging
Translation:Humans Cells
Quantitative tissue oxygen measurement in multiple organs using 19F MRI in a rat model. Magn Reson Med. 2011 Dec; 66(6):1722-30. Liu S, Shah SJ, Wilmes LJ, Feiner J, Kodibagkar VD, Wendland MF, Mason RP, Hylton N, Hopf HW, Rollins MD. PMID: 21688315; PMCID: PMC3186821.

View in: PubMed Mentions: 24 Fields:
Dia Diagnostic Imaging
Translation:Animals
Magnetic resonance imaging for secondary assessment of breast density in a high-risk cohort. Magn Reson Imaging. 2010 Jan; 28(1):8-15. Klifa C, Carballido-Gamio J, Wilmes L, Laprie A, Shepherd J, Gibbs J, Fan B, Noworolski S, Hylton N. PMID: 19631485; PMCID: PMC4087111.

View in: PubMed Mentions: 59 Fields:
Dia Diagnostic Imaging
Translation:Humans
Improved tumor vascular function following high-dose epidermal growth factor receptor tyrosine kinase inhibitor therapy. J Magn Reson Imaging. 2007 Dec; 26(6):1618-25. Moasser MM, Wilmes LJ, Wong CH, Aliu S, Li KL, Wang D, Hom YK, Hann B, Hylton NM. PMID: 17968965; PMCID: PMC3024590.

View in: PubMed Mentions: 14 Fields:
Dia Diagnostic Imaging
Translation:Animals
Kinetic assessment of breast tumors using high spatial resolution signal enhancement ratio (SER) imaging. Magn Reson Med. 2007 Sep; 58(3):572-81. Li KL, Henry RG, Wilmes LJ, Gibbs J, Zhu X, Lu Y, Hylton NM. PMID: 17685424; PMCID: PMC4508009.

View in: PubMed Mentions: 23 Fields:
Dia Diagnostic Imaging
Translation:Humans Animals Cells
Type I collagen is a genetic modifier of matrix metalloproteinase 2 in murine skeletal development. Developmental Dynamics. 2007 Aug 1; 236(8):spc1-spc1. Egeblad EM, Shen SH, Behonick BD, Wilmes WL, Eichten EA, Korets KL, Kheradmand KF, Werb WZ, Coussens CL. .

View in: Publisher Site Mentions:
Type I collagen is a genetic modifier of matrix metalloproteinase 2 in murine skeletal development. Dev Dyn. 2007 Jun; 236(6):1683-93. Egeblad M, Shen HC, Behonick DJ, Wilmes L, Eichten A, Korets LV, Kheradmand F, Werb Z, Coussens LM. PMID: 17440987; PMCID: PMC2581616.

View in: PubMed Mentions: 23 Fields:
Ana Anatomy
Translation:Humans Animals
AG-013736, a novel inhibitor of VEGF receptor tyrosine kinases, inhibits breast cancer growth and decreases vascular permeability as detected by dynamic contrast-enhanced magnetic resonance imaging. Magn Reson Imaging. 2007 Apr; 25(3):319-27. Wilmes LJ, Pallavicini MG, Fleming LM, Gibbs J, Wang D, Li KL, Partridge SC, Henry RG, Shalinsky DR, Hu-Lowe D, Park JW, McShane TM, Lu Y, Brasch RC, Hylton NM. PMID: 17371720.

View in: PubMed Mentions: 58 Fields:
Dia Diagnostic Imaging
Translation:Animals
Characterization of breast lesions using the 3D FIESTA sequence and contrast-enhanced magnetic resonance imaging. J Magn Reson Imaging. 2007 Jan; 25(1):82-8. Klifa CS, Shimakawa A, Siraj Z, Gibbs JE, Wilmes LJ, Partridge SC, Proctor E, Hylton NM. PMID: 17173311.

View in: PubMed Mentions: 3 Fields:
Dia Diagnostic Imaging
Translation:Humans
Heterogeneity in the angiogenic response of a BT474 human breast cancer to a novel vascular endothelial growth factor-receptor tyrosine kinase inhibitor: assessment by voxel analysis of dynamic contrast-enhanced MRI. J Magn Reson Imaging. 2005 Oct; 22(4):511-9. Li KL, Wilmes LJ, Henry RG, Pallavicini MG, Park JW, Hu-Lowe DD, McShane TM, Shalinsky DR, Fu YJ, Brasch RC, Hylton NM. PMID: 16161072.

View in: PubMed Mentions: 27 Fields:
Dia Diagnostic Imaging
Translation:Humans Animals